A strand of silk strung together the four "firsts" of the industry, modern hardware "breaks through the cocoon" and flies into the healthy track
On March 12th, Hu Jirong, President of Xingyue Group, announced to the public that Zhejiang Xingyue Biotechnology Co., Ltd. (hereinafter referred to as "Xingyue Biotechnology") has a new biomaterial and its application: applying silk fibroin protein to the health field; The high-end medical beauty brand "Silky Beauty" under Xingyue Biotechnology has officially debuted in the global market. This old entrepreneur from Yongkang, who made a fortune in the hardware industry, won applause from over a hundred guests, industry colleagues, and professional scholars in an instant.
The release of the achievements brand of Xingyue Biotechnology is like the emergence of a healthy track for modern hardware, providing a template for the transformation and upgrading of the city's industrial economy, and fully reflecting the vigorous development of 'new quality productivity', "said Zhao Hongshi, Chief Technology Officer of Xingyue Biotechnology excitedly.
It is reported that silk fibroin is a natural protein extracted from silk. It is homologous with human epidermal protein and can be directly absorbed by the human body. It is rich in 18 kinds of amino acids contained in the human body. It is nutritious, with glycine, alanine and serine accounting for more than 80%. The amino acids and polypeptides produced by degradation can be absorbed and utilized by cells. In tissue repair and regenerative medicine, silk fibroin also has functions such as supporting or enhancing cellular life activities, promoting tissue repair and regeneration, supporting oxygen and nutrient transport, etc. It can achieve and maintain intercellular interactions, accelerate wound closure and neovascularization, and promote wound healing.
The reporter learned that under the "shaping" of high technology, the silk fibroin has already surpassed the traditional use of textile fabrics and gradually developed into advanced biopolymer polymers. As a new material in regenerative medicine, it has great potential for development in fields such as healthcare, environmental protection, and biotechnology.
Although Xingyue Biotechnology was founded in 2010, the group's R&D team had already started researching the application of silk fibroin in the medical field as early as 19 years ago. Nowadays, the company's 10000 level R&D production workshop adopts medical standard production management and control, which can achieve a purity of up to 99.9% for extracted silk fibroin. "Zhao Hongshi, the company's Chief Technology Officer, said that for more than a decade, by connecting the entire chain of basic research, raw material technology, and industrial transformation, the company has become a platform enterprise in the silk fibroin industry chain, and gradually covers the application scenarios of silk fibroin to multiple fields such as medicine, tissue engineering, medical beauty, and cosmetics with high standards for medical devices.
After ten years of sharpening a sword, it will be astonishing when unsheathed. Nowadays, Xingyue Biotechnology is gradually leading the industrial revolution in the silk fibroin industry. In 2020, we obtained China's first Class III medical device registration certificate for silk fibroin. In 2021, we completed the clinical trial report for the first silk fibroin product implanted in the human body that officially entered clinical trials in China. In the same year, we obtained China's first silk fibroin medical raw material master document. In 2022, we participated in the formulation of China's first medical silk fibroin industry standard and officially submitted it for approval.
New quality productivity refers not only to production, but also to the innovation of the entire industrial chain, the formation of new productivity, and the matching of national high-quality development. The biopharmaceutical industry is a strategic emerging industry that is related to national economy, people's livelihood, and national security, and is of great significance for the development of new quality productivity. "Zhao Hongshi said that compared with the mature" capital+technology "promotion method abroad, China mainly adopts the combination of universities and scientific research, and implements the development of industry university research projects. He believes that "new quality productivity" is a system of technological breakthroughs. To keep up with the pace of the times, enterprises must adhere to independent innovation, build a collaborative innovation transformation mechanism, and firmly grasp the lifeline of development in their own hands. Hu Jirong has a more concise understanding of "new quality productivity": the so-called new quality productivity refers to enterprises increasing research costs, ordinary people reducing consumption costs, allowing high-end new materials to enter ordinary people's homes, and doing "small things" for everyone's health and beauty.
Article source: Yongkang Integrated Media Center
